Accuredit Therapeutics Appointed Dr. Fuxin Shi as Head of New Drug Discovery & Preclinical Research and General Manager of the US Subsidiary

Accuredit Therapeutics Appointed Dr. Fuxin Shi as Head of New Drug Discovery & Preclinical Research and General Manager of the US Subsidiary - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

China ,United States ,Suzhou ,Jiangsu ,Fuxin Shi ,Liaoning ,Nicole Zhang ,Yongzhong Wang ,Prnewswire Accuredit Therapeutics Suzhou Co ,Harvard University ,National Institutes Of Health ,Accuredit Therapeutics Suzhou Co ,Preclinical Research ,Novartis ,General Manager ,National Institutes ,Decibel Therapeutics ,Frequency Therapeutics ,Xinghu Street ,Industrial Park ,Resume ,Careers ,Ccuredit Therapeutics Appointed Dr Fuxin Shi As Head Of New Drug Discovery Amp Preclinical Research And General Manager The Us Subsidiary ,Iospace ,Advice ,